'Never exported vaccines at the cost of people of India': Adar Poonawalla
Pune/IBNS: Adar Poonawalla, CEO of Serum Institute of India (SII), the manufacturer of Covishield, on Tuesday said that his company has "never exported vaccines at the cost of the people of India".
Widening gap between two Covishield doses not cover-up, says Dr Anthony Fauci
New Delhi/IBNS: White House chief medical adviser Dr Anthony Fauci has backed the Indian government's approach to intensify the Covid-19 vaccination drive as it is the key to ending coronavirus crisis in India and called the decision to increase the gap between two doses of Covishield as a "reasonable approach", according to an ANI report.
Good scientific decision: Adar Poonawalla on increase in gap between Covishield doses
New Delhi/IBNS: Adar Poonawalla, the CEO of Serum Institute of India (SII) that manufactures anti-Covid-19 vaccine Covishield, has welcomed the central government's decision to increase the gap between the first and second doses of the vaccine to 12-16 weeks.
Govt panel recommends 12-16 week gap between Covishield doses
New Delhi/IBNS: A government panel on Thursday recommended an increase in the gap between the first and second doses of anti-Covid-19 vaccine, Covishield, to 12-16 weeks.
My comments have been misinterpreted: Adar Poonawalla clarifies on interview with UK media
London/IBNS: Serum Institute of India (SII) CEO Adar Poonawalla on Monday said his comments made last week to British newspaper The Times, in which he spoke about "aggressive" phone calls from influential people in India demanding an increased production of Covishield vaccine, have been "misinterpreted".
London: Amid India's catastrophic Covid19 crisis and demand for vaccines, Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said he was under pressure and aggression over vaccines is overwhelming. He also hinted at starting production outside India in a country like Britain.
Kejriwal gets second dose of COVID vaccine
New Delhi/UNI: Delhi Chief Minister Arvind Kejriwal on Thursday received the second shot of COVID vaccine Covishield.
New Delhi/IBNS: Mounting pressure further on the Centre, several opposition leaders have criticised the Narendra Modi government over the difference in prices at which the Serum Institute of India (SII) has decided to sell its Covid-19 vaccine to the Centre, states and private hospitals.
Bangladesh requests India to expedite delivery of Covishield
New Delhi/Dhaka/IBNS: The Bangladesh government has requested India to speed up the delivery of 500,000 doses of Covid-19 vaccines to ensure that its immunization programme is not affected.
'Believe Rs 3,000 cr govt aid will reach us soon, didn't wait but borrowed': SII CEO Adar Poonawalla
Mumbai/IBNS: Serum Institute of India (SII) has borrowed money from banks to ramp up the production of Covishield instead of waiting for the government's aid of Rs 3,000 crore to arrive.
No question of lockdown now in Bengal: Mamata Banerjee amid Covid-19 spike
Malda/Kolkata/IBNS: In tune with Prime Minister Narendra Modi's appeal, West Bengal Chief Minister Mamata Banerjee on Wednesday said there would be no lockdown in West Bengal immediately to contain the spread of Covid-19.
Sri Lankan seeks urgent delivery of Covishield from India
The Sri Lankan government is reportedly in touch with Indian officials to seek urgent export of around one million doses of Covishield vaccines from India for the second phase of its vaccination drive, reported Daily Mirror.
AstraZeneca sends legal notice to Serum Institute over delays in vaccine supply
New Delhi/IBNS: Serum Institute of India (SII) has been served a legal notice by AstraZeneca over vaccine supply delays, a Business Standard report said.
Serum Institute seeks financial assistance from govt to boost capacity
New Delhi/IBNS: Adar Poonawalla, the CEO of world's largest vaccine manufacturer Serum Institute of India (SII), has told NDTV it needs Rs 3,000 crore in assistance from the Indian government to expand its production capacity which is currently "very stretched" in wake of the export restrictions imposed by the government last month.
Australian High Commissioner to India in New Delhi Barry O'Farrell takes Covid-19 vaccine shot
New Delhi/IBNS: Australian High Commissioner to India in New Delhi, Barry O'Farrell, took the Covid-19 vaccine shot here on Tuesday.